{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:55:40Z","timestamp":1791197740086,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,11]],"date-time":"2014-12-11T00:00:00Z","timestamp":1418256000000},"content-version":"vor","delay-in-days":344,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ajpath.2013.09.022","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T08:48:49Z","timestamp":1383814129000},"page":"79-85","source":"Crossref","is-referenced-by-count":32,"title":["Ras-Mek-Erk Signaling Regulates Nf1 Heterozygous Neointima Formation"],"prefix":"10.1016","volume":"184","author":[{"given":"Brian K.","family":"Stansfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waylan K.","family":"Bessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghuveer","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Mund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D.","family":"Downing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"David A.","family":"Ingram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2013.09.022_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Chang","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.09.022_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI41443","article-title":"Genetic and cellular\u00a0evidence of vascular inflammation in neurofibromin-deficient mice and humans","volume":"120","author":"Lasater","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.09.022_bib3","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/hmg\/ddl114","article-title":"Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells","volume":"15","author":"Li","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2013.09.022_bib4","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/hmg\/ddl108","article-title":"Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells","volume":"15","author":"Munchhof","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2013.09.022_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00125817-200205000-00002","article-title":"Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force","volume":"4","author":"Friedman","year":"2002","journal-title":"Genet Med"},{"key":"10.1016\/j.ajpath.2013.09.022_bib6","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1093\/hmg\/ddn134","article-title":"Nf1+\/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway","volume":"17","author":"Lasater","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2013.09.022_bib7","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1084\/jem.187.11.1893","article-title":"Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines","volume":"187","author":"Zhang","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.ajpath.2013.09.022_bib8","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/hmg\/dds502","article-title":"Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway","volume":"22","author":"Stansfield","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2013.09.022_bib9","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2013.09.022_bib10","doi-asserted-by":"crossref","first-page":"76ra27","DOI":"10.1126\/scitranslmed.3001069","article-title":"A MEK inhibitor abrogates myeloproliferative disease in Kras mutant mice","volume":"3","author":"Lyubynska","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ajpath.2013.09.022_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00280-011-1620-1","article-title":"Pilot study of PD-0325901 in previously treated patients with advanced melanoma, breast cancer, and colon cancer","volume":"68","author":"Boasberg","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ajpath.2013.09.022_bib12","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/1078-0432.CCR-09-1920","article-title":"A phase II study of PD-0325901, an oral MEK inhibitor, in previously treated patients with advanced non-small cell lung cancer","volume":"16","author":"Haura","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2013.09.022_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/01.ATV.0000250606.70669.14","article-title":"M-CSF accelerates neointimal formation in the early phase after vascular injury in mice: the critical role of the SDF-1-CXCR4 system","volume":"27","author":"Shiba","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2013.09.022_bib14","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1182\/blood-2003-08-2650","article-title":"Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder","volume":"103","author":"Le","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ajpath.2013.09.022_bib15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/ATVBAHA.109.200501","article-title":"Blockade of the Ras-extracellular signal-regulated kinase 1\/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia","volume":"30","author":"Dong","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2013.09.022_bib16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.a.33183","article-title":"Proceedings from the 2009 genetic syndromes of the Ras\/MAPK pathway: from bedside to bench and back","volume":"152A","author":"Rauen","year":"2010","journal-title":"Am J Med Genet Part A"},{"key":"10.1016\/j.ajpath.2013.09.022_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1006\/jsre.2000.6014","article-title":"Effects of active and negative mutants of Ras on rat arterial neointima formation","volume":"94","author":"Jin","year":"2000","journal-title":"J Surg Res"},{"key":"10.1016\/j.ajpath.2013.09.022_bib18","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/01.RES.0000149518.86865.3e","article-title":"Crucial role of the CCL2\/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets","volume":"95","author":"Schober","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2013.09.022_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00005344-200311000-00014","article-title":"Systemic depletion of macrophages by liposomal bisphosphonates reduces neointimal formation following balloon-injury in the rat carotid artery","volume":"42","author":"Danenberg","year":"2003","journal-title":"J Cardiovasc Pharmacol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013006792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944013006792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:53:26Z","timestamp":1539219206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944013006792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0002944013006792"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2013.09.022","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]}}}